CKAP4 and PLOD2 as novel prognostic biomarkers in hepatocellular carcinoma: a proteomics-driven risk stratification model
Qianjin Lu(Central South University), Hong Shu(Central South University), Yueting Xiong(Fudan University), Zhijian Chen(Bristol-Myers Squibb (Germany)), Xiaohui Liu(Shanghai Jiao Tong University), Xinxian Long(Guangxi Medical University), You Shu(Guangxi Medical University), Junqiang Huang(Guangxi Medical University), Zhao Cao(Guangxi Medical University), Huan Zeng(Guangxi Medical University)
Cited by 3
Related Papers
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
|Nature Genetics|2009|951
Demethylation of <i>CD40LG</i> on the Inactive X in T Cells from Women with Lupus
|The Journal of Immunology|2007|466
Induced Regulatory T Cells: Their Development, Stability, and Applications
|Trends in Immunology|2016|451
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
|Clinical Reviews in Allergy & Immunology|2013|372